GLAXOSMITHKLINE general manager Anne Belcher appears in a new video from the company in which she discusses the challenges of vaccine manufacture and GSK's efforts to increase supply.
Belcher confirms that recently there has been a global increase in demand for Bexsero (meningococcal B) vaccine which has also been reflected here, meaning supply to Australia isn't meeting current demand.
GSK is increasing supply by five times last year's volumes - see pharmacydaily.com.au/videos.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Feb 17
